secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2026-05-29T11:00:25+00:00
Accession:  0001178913-26-002988
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted
-------------------------------------------------------------------------------

- 1-for-10 reverse share split effective after close May 28; shares trade on split-adjusted basis May 29 under ticker SLXN.
- Authorized shares reduced to 5.9M; par value increased to $0.135 per share.
- Each warrant now exercisable for 1/10 share at $15,525.00 per whole share (was $1,552.50).
- Shareholders approved reverse split at reconvened EGM on May 5, 2026.
- Split intended to maintain compliance with Nasdaq minimum bid price requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/0001178913-26-002988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891326002988/zk2635442.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-002988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer